Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc.verified

GBT

Price:

$68.49

Market Cap:

$0

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemogl...[Read more]

Industry

Biotechnology

IPO Date

2015-08-12

Stock Exchange

NASDAQ

Ticker

GBT

The ROE as of December 2024 (TTM) for Global Blood Therapeutics, Inc. (GBT) is -98.96%

According to Global Blood Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -98.96%. This represents a change of 97.87% compared to the average of -50.01% of the last 4 quarters.

Global Blood Therapeutics, Inc. (GBT) Historical ROE (quarterly & annually)

How has GBT ROE performed in the past?

The mean historical ROE of Global Blood Therapeutics, Inc. over the last ten years is -32.48%. The current -98.96% ROE has changed 204.72% with respect to the historical average. Over the past ten years (40 quarters), GBT's ROE was at its highest in in the June 2015 quarter at 12.70%. The ROE was at its lowest in in the June 2022 quarter at -69.68%.

Quarterly (TTM)
Annual

Average

-32.48%

Median

-36.71%

Minimum

-154.32%

Maximum

69.75%

Global Blood Therapeutics, Inc. (GBT) ROE by Quarter and Year

Discovering the peaks and valleys of Global Blood Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 159.42%

Maximum Annual ROE = 69.75%

Minimum Annual Increase = -178.06%

Minimum Annual ROE = -154.32%

Quarterly (TTM)
Annual
YearROEChange
2021-154.32%159.42%
2020-59.49%29.04%
2019-46.10%51.58%
2018-30.41%-17.15%
2017-36.71%-17.07%
2016-44.26%34.43%
2015-32.93%-178.06%
201442.18%-39.52%

Global Blood Therapeutics, Inc. (GBT) Average ROE

How has GBT ROE performed in the past?

The current ROE of Global Blood Therapeutics, Inc. (GBT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-86.63%

5-year avg

-65.40%

10-year avg

-32.48%

Global Blood Therapeutics, Inc. (GBT) ROE vs. Peers

How is GBT’s ROE compared to its peers?

Global Blood Therapeutics, Inc.’s ROE is

CompanyROEMarket cap

Build a custom stock screener for Global Blood Therapeutics, Inc. (GBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Global Blood Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Global Blood Therapeutics, Inc. (GBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Global Blood Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Global Blood Therapeutics, Inc.'s ROE?

How is the ROE calculated for Global Blood Therapeutics, Inc. (GBT)?

What is the highest ROE for Global Blood Therapeutics, Inc. (GBT)?

What is the 3-year average ROE for Global Blood Therapeutics, Inc. (GBT)?

What is the 5-year average ROE for Global Blood Therapeutics, Inc. (GBT)?

How does the current ROE for Global Blood Therapeutics, Inc. (GBT) compare to its historical average?